Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure (Q46985775)

27 December 2017

title

Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure (English)

1 reference

27 December 2017

1 reference

1

1 reference

27 December 2017

author name string

Ahmed Tageldien Abdellah

2

1 reference

27 December 2017

Olga Khaleva

3

1 reference

27 December 2017

Alison P Coletta

4

1 reference

27 December 2017

Andrew L Clark

5

1 reference

27 December 2017

publication date

24 September 2007

1 reference

27 December 2017

European Journal of Heart Failure

published in

1 reference

27 December 2017

volume

9

1 reference

27 December 2017

page(s)

1070-1073

1 reference

27 December 2017

issue

10

1 reference

27 December 2017

Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.09.005

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.09.005

Therapeutic potential of renin inhibitors in the management of cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.09.005

Cardiac resynchronization therapy or atrio-biventricular pacing-what should it be called?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.09.005

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.09.005

Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and M

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.09.005

Predictors of response to cardiac resynchronization therapy (PROSPECT)--study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.09.005

Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.09.005

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.09.005

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.09.005

The effects of initiation or continuation of statin therapy on cholesterol level and all-cause mortality after the diagnosis of left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.09.005

The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.09.005

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.09.005

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.09.005

10.1016/J.EJHEART.2007.09.005

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

PubMed ID

17890152

1 reference

27 December 2017